NCT00655044View on ClinicalTrials.gov

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

3,637

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Safety and effectiveness data collection in connection with the use of drug Levemir in daily clinical practice.

Trial Locations (1)

119330

Novo Nordisk Investigational Site, Moscow

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00655044 - Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes | Biotech Hunter | Biotech Hunter